Oral Presentations - Late-Breaking Proffered Abstracts最新文献

{"title":"4CPS-238 Profile of elderly patients at high fall risk and polypharmacy in the emergency department","authors":"J. Pedreira Bouzas, C. Puivecino Moreno, Y. Castellanos Clemente, A. Merino García, MJ Canalejo Fuentes, M. García Gil","doi":"10.1136/ejhpharm-2023-eahp.426","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.426","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87888813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"5PSQ-128 Thromboprophylaxis in the emergency department. adequacy of the prescription","authors":"Á. Jofre, JI Bretones, M. Herrera Expósito, J. Urda Romacho, M. C. Castro Vida, J. Canto-Mangana","doi":"10.1136/ejhpharm-2023-eahp.459","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.459","url":null,"abstract":"Background and ImportanceIn Europe, the VITAE study estimates an annual incidence of venous thromboembolic disease (VTD) of 243/100,000 inhabitants.About 25% of VTD cases are related to hospital admissions and 50–75% of VTD cases occur in non-surgical hospitalised patients. PRETEMED is a validated thrombotic risk (TR) scale for clinical prediction that have been designed to be used in daily clinical practice. As well, it is recommended to assess the bleeding risk (BR) with another validated scale called IMPROVE scale before starting thromboprophylaxis (TP).Aim and ObjectivesDetermine the (TR/BR) and analyse whether the prescription of thromboprophylaxis in patients from the Emergency Department who are going to be admitted to the hospital ward is adequate.Material and MethodsProspective observational cohort study, carried out in a 2nd level hospital during a period of 10 days. Adult patients in the ED awaiting admission to the hospital ward were included.Patients with therapeutic effort limitation, COVID-19 patients, those who had been transfused in the last 48 hours, bleeding patients or those with underlying pathology that require anticoagulation were excluded. Using the PRETEMED/IMPROVE scales, the TR/BR was determined, as well as the indication of thromboprophylaxis.Results62 patients. 31 women (50%). The median age [range] was 71 [18–93] years. 31 patients with TP regimen, no interventions had to be performed, they had an adequate indication with PRETEMED> 4 and IMPROVE <7. 31 patients without TP regimen;7 (23%) of them had indication for TP and they went into the operating room with PRETEMED> 4 and IMPROVE <7. 7 (11.3%) of the patients required pharmaceutical intervention to adequate their TP, all of them by default.Conclusion and RelevanceThe prescription of TP in adults who visit the ED could be considered adequate in a high percentage, however it can be optimised according to the PRETEMED and IMPROVE guidelines. It is essential to recommend on the use of scales that assess TR/BR for the correct decision-making in the prescription of TP. The limitation of the study was the small sample size.References and/or AcknowledgementsConflict of InterestNo conflict of interest","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"458 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82274922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"4CPS-220 Comparative analysis of skin toxicity on patients with metastatic colon cancer treated with epidermal growth receptor blocking drugs","authors":"B. Aparicio, A. Gago-Sánchez, N. Báez-Gutiérrez, E. Mancilla Montero, L. Ruiz-Lara","doi":"10.1136/ejhpharm-2023-eahp.420","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.420","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77642587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"5PSQ-017 Immune-mediated adverse effects of chimeric antigen receptor t cells (CAR-T) therapy in real life population: we continue to learn","authors":"D. Gómez, C. Serra, G. Marina, V. Escudero, Jl Revuelta, Y. Rioja, G. Oarbeascoa, A. Herran, M. Sanjurjo","doi":"10.1136/ejhpharm-2023-eahp.438","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.438","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"304 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73607492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"4CPS-214 Real-life results on the use of trastuzumab emtansine in her2-positive metastatic breast cancer","authors":"L. Torralba, N. Labrador, M. Toledo, C. Jimenez, R. Prieto, A. Rubio, A. Domínguez, P. Moya","doi":"10.1136/ejhpharm-2023-eahp.419","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.419","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77700857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"5PSQ-015 Persistence of treatment with jak inhibitors in rheumatoid arthritis in patients already treated with them","authors":"FÁ Lao Domínguez, JM Espina Lozano, MJ Fobelo Lozano, J. Uceda Montañés","doi":"10.1136/ejhpharm-2023-eahp.437","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.437","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87533564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"4CPS-244 Analysis and comparison of olanzapine administration in smoking and non-smoking patients","authors":"C. García González, G. Martínez Orea, F. Fuentes Hidalgo, A. Candela Fajardo, R. Bonilla Peñarrubia, N. Cano Cuenca","doi":"10.1136/ejhpharm-2023-eahp.428","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.428","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86857917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2SPD-012 Comparative efficacy of abrocitinib, baricitinib and upadacitinib in monotherapy for the treatment of atopic dermatitis","authors":"R. Claramunt García, C. Muñoz Cid, A. Sánchez Ruiz, N. García Gomez, M. Merino Almazán, T. Sánchez Casanueva","doi":"10.1136/ejhpharm-2023-eahp.362","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.362","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"183 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86228456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"5PSQ-105 Development of hypomagnesemia in critical patients treated with isavuconazole","authors":"G. Martínez Orea, C. García González, F. Fuentes Hidalgo, C. Devesa García, R. Bonilla Peñarrubia, A. Candela Fajardo","doi":"10.1136/ejhpharm-2023-eahp.453","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.453","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"138 40","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91403101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"5PSQ-018 Prescribing errors in children: what is the impact of a computerised physician order entry?","authors":"A. Satir, M. Pfiffner, C. Meier, A. Caduff Good","doi":"10.1136/ejhpharm-2023-eahp.439","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.439","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84804958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}